You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Circulating Diagnostic Markers of Infectious Disease
SBC: PATHOVACS INCORPORATED Topic: CBD18A001The focus of this STTR phase I component is on proof-of-concept studies demonstrating applicability of technical approaches for identificationof circulatory diagnostic markers for infectious disease. Therefore, the primary objective of this project is to determine feasibility of one suchtechnical approach called Proteomics-based Expression Library Screening (PELS), for identification of pathogen-d ...
STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense -
Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases
SBC: CFD RESEARCH CORPORATION Topic: CBD18A001In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens,whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial andalphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable and ...
STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense -
Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point ofCare Applications
SBC: GENECAPTURE, INC. Topic: CBD15C001GeneCapture, Inc. is proposing to develop a rapid in vitro diagnostic prototype using our patented molecular-based CAPTURE (ConfirmActive Pathogens Through Unamplified RNA Expression) assay. Based on the results and experience gained in our Phase I STTR contractHDTRA1-16C-0061: Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications, we p ...
STTR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense -
Medical Device to Assess the Viability of Tissue Prior to Skin Grafting
SBC: Spectral Md, Inc. Topic: DHP17A006The primary objective of this Phase II proposal is to construct and validate the portable SpectralMD DeepView imaging technology designed previously in Phase I. This device allows surgeons to quickly and objectively assess tissue viability in burn surgery prior to skin grafting. DeepView uses machine learning and multispectral imaging to generate quantitative prognostic images with easily interpre ...
STTR Phase II 2018 Department of DefenseDefense Health Agency -
Point of care, microfluidic, multi-electrode and optical hybrid CBC
SBC: LYNNTECH INC. Topic: DHA172008Lynntech will design and build a laboratory scale reduced weight, environmentally stable, CBC device which is usable at Role 1 and higher which requires no cold chain storage. The device is specifically intended to be used by medical personnel deployed in Health Response Teams (HRTs) who are not lab technicians and who do not have rapid, reliable access to a hematology lab. To this end, the soluti ...
SBIR Phase I 2018 Department of DefenseDefense Health Agency -
Injectable Bio-compatible gel composed of iPSC derived NSC for regeneration of brain tissue
SBC: FABRICO TECHNOLOGY, INC. Topic: DHA18004Stem cell apoptosis occurs when the interaction between the host brain extracellular matrix (ECM) and human induced pluripotent stem cell (iPSC) derived neural stem cell (NSCs) are directly injected into the injured brain regions. Establishment of a connection between ECM and iPSC/NSC could increase cell viability, differentiation, and promote functional recovery of the injured tissue. The critica ...
SBIR Phase I 2018 Department of DefenseDefense Health Agency -
Field portable Coliform bacteria & E. Coli RNA biomarker LAMP- OSD system
SBC: FABRICO TECHNOLOGY, INC. Topic: DHA17004Fabrico Technology, Dr. Sanchita Bhadra and Professor Andrew Ellington of the University of Texas at Austin, have successfully demonstrated the proof-of-concept of an unparalleled, first-in-class in-field nucleic acid diagnostic platform for distinction of viable from non-viable E. coli and coliforms in
SBIR Phase II 2018 Department of DefenseDefense Health Agency -
Dynamics for Warfighter Avatars with Complete Articulated Anatomy
SBC: CFD RESEARCH CORPORATION Topic: DHA17003Complete human anatomy avatars have a broad role in advanced training environments, performance-related physiological modeling, and simulations for the purpose of designing protective armor. The overall goal of this project is to design and develop computer software and data structures for adding articulated joints and natural motions to USARIEMs static finite element avatars and to create a graph ...
SBIR Phase II 2018 Department of DefenseDefense Health Agency -
MicroLens Hyperspectral Imager for Standoff Chemical Detection
SBC: NANOHMICS INC Topic: CBD171002For standoff chemical identification applications, the longwave infrared has several key lines for spectral discrimination.Unfortunately, most hyperspectral systems are quite large, making them unwieldy.Nanohmics proposes to develop a chip-scale longwave infrared hyperspectral imaging technology.The weight and packaging volume will be dominated by the fore-optics instead of the spectroscopy soluti ...
SBIR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense -
Additive Manufacturing of Made-To-Measure Respiratory Protection Systems
SBC: AZUL 3D INC Topic: CBD181001CDJ Technologies is an additive manufacturing (AM) company with technology that enables rapid printing over large build volumes. Thisresultant production throughput is differentiating within the AM technology space and enables the adoption of AM technology to addresslimited production-runs. There exist many items where the ability to customize a single component of a system can add substantial val ...
SBIR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense